This site is intended for health professionals only
Wednesday 12 December 2018
Share |

Topic: Patient safety

October 25, 2018
Six-week no-deal Brexit drugs stockpile could take over a year to prepare

Stockpiling six weeks worth of medicines after a no-deal Brexit could take over a year due to creating extra storage for drugs that need to be kept in certain conditions, a Government committee has heard.
 
Speaking before the Health and Social Care Committee on Tuesday [23 October], wholesalers’ body the Healthcare Distribution Association (HDA) executive director Martin Sawer explained that building new cold-chain warehouses for medicines that need refrigeration might take more than a year.
 

October 17, 2018
Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the Government has said.

Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the UK Government has said.
 

August 23, 2018
Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska

Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska
 
What with busy dispensaries and tricky patients to contend with, life as a pharmacist can present challenges in any walk of the profession.
 

August 14, 2018
The prescribing safety assessment (PSA) could benefit pre-registration pharmacy students who want to become independent prescribers, a study has concluded.

The prescribing safety assessment (PSA) could benefit UK pre-registration pharmacy students who want to become independent prescribers, a study has concluded.
 
The PSA is a 60-minute evaluation of 30 questions on writing and reviewing new prescriptions, calculating drug doses and identifying and avoiding adverse drug reactions and medication errors, among others.
 

July 11, 2018
The European anti-counterfeiting measures will come into force in February. Léa Legraien gives pharmacists all the information they need to make sure they’re ready

The European anti-counterfeiting measures will come into force in February. Lea Legraien gives pharmacists all the information they need to make sure they’re ready 
 
The Falsified Medicines Directive (FMD) will come into force on 9 February 2019 in the UK, as mandated by the European Commission (EC), to tackle counterfeit medicines and improve patient safety.
 

May 11, 2018
Neuromuscular blocking agents have a well-documented history of causing catastrophic injuries or death when inadvertently administered to adult and paediatric patients who were not receiving proper ventilatory assistance

Because neuromuscular blockers paralyse the muscles necessary for breathing, some patients have died or sustained serious, permanent injuries if the paralysis was not witnessed by a practitioner who could intervene.

 

May 10, 2018
Patients being discharged from hospital care are set to benefit from a new system that enables and speeds up communication with community pharmacists, improving patient safety

Eastern AHSN is rolling out a new electronic medication optimisation pathway (EMOP) for the east of England, to ensure patients get the most from their medicines and remain in a better state of health, with support from their community pharmacist.
 

March 1, 2018
Simplified administration and improved safety (needle protection) associated with greater treatment compliance

In January 2013, Medac, the market leader in parenteral methotrexate (MTX), introduced MTX in the pharmaceutical form of a pre-filled pen in Germany for the first time worldwide. This was a brand-new innovation for doctors, practice teams and patients who, until then, had been used to the established methotrexate pre-filled syringe metex®.1

May 31, 2016
The Falsified Medicines Directive, which requires complete compliance by February 2019 mandates the systematic authentication of medicines at the point of supply to the patient, in an effort to identify counterfeit, falsified, recalled or expired drugs

The sale of medicines known to be counterfeit or falsified is an unscrupulous business that endangers patient health. The Falsified Medicines Directive (FMD), which requires complete compliance by February 2019 mandates the systematic authentication (scanning) of medicines at the point of supply to the patient, in an effort to identify counterfeit, falsified, recalled or expired drugs. The FMD is a win-win-win for government, the pharmaceutical industry and patients, but it remains to be seen how this change will affect the secondary care environment.

December 10, 2015
2600 hospital pharmacies targeted with single set of clear information for patients

In the largest ever coordinated communication of its type, the British Generic Manufacturers Association (BGMA) has distributed patient information aimed at removing unnecessary duplication and improving impact when contacting pharmacists, GPs and other healthcare professionals about important safety information.
 

 

December 10, 2015
2600 hospital pharmacies targeted with single set of clear information for patients

In the largest ever coordinated communication of its type, the British Generic Manufacturers Association (BGMA) has distributed patient information aimed at removing unnecessary duplication and improving impact when contacting pharmacists, GPs and other healthcare professionals about important safety information.
 

 

September 22, 2015
FIP produces Arabic pictograms to help refugees with their medicines

The global refugee crisis, particularly the nine million Syrians estimated to have fled their homes since 2011, has prompted the International Pharmaceutical Federation (FIP) to undertake urgent work to help pharmacists ensure that refugees who need medicines understand how to take them. An Arabic version of the FIP pictogram software has been released. FIP’s pictograms provide a means of communicating medication instructions when there is no common language or when patients have low literacy levels.
 

 

September 2, 2015
The healthcare needs of people living in nursing homes are rising due the fact that there is a population with increasing frailty and comorbidities

The healthcare needs of people living in nursing homes are rising due the fact that there is a population with increasing frailty and comorbidities. I work in Group Mutuam that provides healthcare in geriatrics, including sub-acute, nursing homes, primary care and home care. We have Healthcare Teams (physicians and nurses) that attend inpatients in nursing homes; from the Pharmacy Service; we give them support in all areas related to medication.

 

August 10, 2015
The solution by Schreiner MediPharm and Edelmann: the package insert is easy to access by pharmacists and patients without affecting the first-opening protection of the pack

Schreiner MediPharm has developed in a joint project with the packaging manufacturer Edelmann an innovative solution that makes important product information accessible without opening the pharmaceutical pack. The packaging solution is based on the requirements of the EU Falsified Medicines Directive 2011/62/EU.

 

August 10, 2015
This article highlights the many ways in which pharmacists in hospital and community settings can influence antimicrobial stewardship (AMS)

 

June 24, 2015
Data presented at the recent American Society of Clinical Oncology (ASCO) Annual Meeting 2015 by Bristol-Myers Squibb (BMS) suggests that its Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape once it is approved, says an analyst with research and consulting firm GlobalData.

Data presented at the recent American Society of Clinical Oncology (ASCO) Annual Meeting 2015 by Bristol-Myers Squibb (BMS) suggests that its Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape once it is approved, says an analyst with research and consulting firm GlobalData.

 

May 28, 2015
The benefits and experiences of implementing summary care record viewing in a UK mental health Trust are examined

 

April 21, 2015
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is done to develop new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is done to develop new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.

April 9, 2015
A new version of the Right Route: Right Care campaign launched today by Pfizer Healthy Partnerships (PHP) with endorsement from Pharmacy Voice, aims to support pharmacy teams in encouraging the public to make the most effective use of their local NHS services, using a simple traffic light system.

A new version of the Right Route: Right Care campaign launched today by Pfizer Healthy Partnerships (PHP) with endorsement from Pharmacy Voice, aims to support pharmacy teams in encouraging the public to make the most effective use of their local NHS services, using a simple traffic light system.
 

November 17, 2014
A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines with 66% reporting this as a daily or weekly problem. The top affected areas are medicines to fight infection, cancer drugs and anaesthetics.

A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines with 66% reporting this as a daily or weekly problem. The top affected areas are medicines to fight infection, cancer drugs and anaesthetics.
 

November 17, 2014
A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines with 66% reporting this as a daily or weekly problem. The top affected areas are medicines to fight infection, cancer drugs and anaesthetics.

A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines with 66% reporting this as a daily or weekly problem. The top affected areas are medicines to fight infection, cancer drugs and anaesthetics.
 

September 5, 2014
Early in 2015, patients will have a new tool that will enable them to know for sure whether they are obtaining medicines, health information and services from websites that are authentic and safe.

Early in 2015, patients will have a new tool that will enable them to know for sure whether they are obtaining medicines, health information and services from websites that are authentic and safe.

 

September 2, 2014
B. Braun Medical Ltd has a long heritage in the delivery of intravenous pharmaceuticals and associated products to markets in the UK and Europe.

B. Braun Medical Ltd has a long heritage in the delivery of intravenous pharmaceuticals and associated products to markets in the UK and Europe.

As part of its continued commitment to sharing expertise, B. Braun is delighted to invite you to the seventh pharmacy workshop, dedicated to providing insight, information and guidance in relation to improving patient safety with injectable medicines.

July 8, 2014
mHealth applications linked to the use of medicines must have levels of regulatory oversight, ideally involving pharmacist expertise, in order to ensure their safety.

mHealth applications linked to the use of medicines must have levels of regulatory oversight, ideally involving pharmacist expertise, in order to ensure their safety.

This is the stance taken by the European Commission (EC), which has been backed by the European Association of Hospital Pharmacists (EAHP).

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine